Implementing group visits for opioid use disorder: A case series

References

• CDC, National Center for Health Statistics Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA; 2017. Available at http://wonder.cdc.gov.
   Google Scholar
• Mortality in the United States, 2016 NCHS Data Brief. No 293, December 2017.
   Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014;(2):CD002207.
   PubMed Web of Science ®Google Scholar
• Mitzner IL, Eisenberg M, Terra M, et al. Treating Opioid Addiction With Buprenorphine in Community-Based primary care settings. Ann Fam Med. 2007;5(2):146–150.
   PubMed Web of Science ®Google Scholar
• Fudala PJ, Bridge TP, Herbert S. Office-Based Treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349(10):949–958.
   PubMed Web of Science ®Google Scholar
• Fiellin DA, O’Connor PG, Clinical P. Office-based treatment of opioid-dependent patients. N Engl J Med. 2002;347(11):817–823.
   PubMed Web of Science ®Google Scholar
• National Consensus Development Panel on Effective medical Treatment of Opioid Addiction. Effective medical treatment of opioid addiction. JAMA. 1998;280(22):1936–1943.
   PubMed Web of Science ®Google Scholar
• Clark RE, Samnaliev M, Baxter JD, Leung GY. The evidence doesn’t justify steps by state medicaid programs to restrict opioid addiction treatment with buprenorphine. Health Aff. 2011;30(8):1425–1433.
   Web of Science ®Google Scholar
• Barry DT, Moore BA, Pantalon MV, et al. Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. J Gen Intern Med. 2007;22 (2):242–245.
   PubMed Web of Science ®Google Scholar
• Rowe T, Jacapraro J, Rastegar D. Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems. Addict Sci Clin Pract. 2012;7(1):22–22.
   PubMedGoogle Scholar
• Sokol R, LaVertu AE, Morrill D, Albanese C, Schuman-Olivier Z. Group-Based treatment of opioid use disorder with buprenorphine: a systematic review. J Subst Abuse Treat. 2018;84:78–87.
   PubMed Web of Science ®Google Scholar
• Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction: A Treatment Improvement Protocol TIP 41. Substance Abuse and Mental Health Services Administration, 2004. Web.
   Google Scholar
• Flores PJ. Group Psychotherapy with Addicted Populations. New York, NY: Haworth, 1988. Print.
   Google Scholar
• Stinchfield R, Owen PL, Winters KC. Chapter 13 Group therapy for substance abuse: A review of the empirical research group. In: Fuhriman A, Burlingame G. 1st ed. Handbook of Group Psychotherapy: An Empirical and Clinical Synthesis. New York, NY: John Wiley; 1994:3–40.
   Google Scholar
• Washton AM. Structured outpatient group therapy with alcohol & substance abusers. In Lowinson J, Ruiz P, Millman R. Eds.Substance Abuse: A Comprehensive Textbook. Baltimore, MD: Williams and Wilkens; 1992.
   Google Scholar
• Sokol R, Albanese C, Chaponis D, et al. Schuman-Olivier Z.Why use group visits for opioid use disorder treatment in primary care? A Patient-Centered Qualitative Study. Subst Abus. 2017;(19):1–7.
   Google Scholar
• National Institute on Drug Abuse (NIDA). Report of the Adoption of NIDA’s Evdience-Based Treatments in Real World Settings Workgroup. 2012. https://www.drugabuse.gov/sites/default/files/files/evidence-based_treatments_in_real_world_settings_workgroup_report.pdf
   Google Scholar
• LaBelle CT, Han SC, Bergeron A, Samet JH. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): statewide implementation of the massachusetts collaborative care model in community health centers. J Subst Abuse Treat. 2016;60:6–13.
   PubMedGoogle Scholar
• Suzuki J, Zinser J, Klaiber B, et al. Feasibility of implementing shared medical appointments (SMAs) for office-based opioid treatment with Buprenorphine: A pilot study. Subst Abus. 2015;36(2):166–169.
   PubMed Web of Science ®Google Scholar
• Lee JD, Vocci F, Fiellin DA. Unobserved “home” induction onto buprenorphine. J Addict Med. 2014;8(5):299–308.
   PubMed Web of Science ®Google Scholar
• Martin SA, Chiodo LM, Bosse JD, Wilson A. The next stage of buprenorphine care for opioid use disorder. Ann Intern Med. 2018;169(9):628–635.
   PubMed Web of Science ®Google Scholar
• Dimeff LA, Linehan MM. Dialectical behavior therapy for substance abusers. Addict Sci Clin Pract. 2008;4(2):39–47.
   PubMedGoogle Scholar
• Schwartz RC. Moving from acceptance toward transformation with Internal Family Systems Therapy (IFS). J Clin Psychol. 2013;69(8):805–816.
   PubMed Web of Science ®Google Scholar
• Sahdick NA, et al. A randomized controlled trial of an internal family systems-based psychotherapeutic intervention on outcomes in rheumatoid arthritis: a proof-of-concept study. J Rheumatol. 2013; 40(11):1831–1841.
   PubMed Web of Science ®Google Scholar
• Bowen S, Witkiewitz K, Clifasefi SL, et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry. 2014;71(5):547–556.
   PubMed Web of Science ®Google Scholar
• Petry NM, Alessi SM, Ledgerwood DM. A randomized trial of contingency management delivered by community therapists. J Consult Clin Psychol. 2012;80(2):286–298.
   PubMed Web of Science ®Google Scholar
• American Academy of Family Physicians (AAFP) American Academy of Pediatrics (AAP) American College of Physicians (ACP) American Osteopathic Association (AOA). Joint Principles of the Patient-Centered Medical Home March 2007. Available at: http://www.aafp.org/dam/AAFP/documents/practice_management/pcmh/initiatives/PCMHJoint.pdf
   Google Scholar
• Eisenstat S, Siegel A, Carlson K, Ulman K. Women’s Health Association, The John D. Stoeckle Center for Primary Care Innovation, Massachusetts General Hospital. Putting group visits into practice: A practical overview to preparation, implementation, and maintenance of group visits at Massachusetts General Hospital. Boston, 2012: 1–26.
   Google Scholar
• Lyon R, Slawson J. An organized approach to chronic disease management. Fam Pract Manag. 2011;18(3):27–31.
   PubMedGoogle Scholar
• Safford B, Manning C. 6 characteristic of effective practice teams. Fam Pract Manag. 2012;(19)3:26–30.
   PubMedGoogle Scholar
• Oser C, Biebel E, Pullen E, Harp K. Causes, consequences, and prevention of burnout among substance abuse treatment counselors: A rural versus urban comparison. J Psychoactive Drugs. 2013;45(1):17–27.
   PubMed Web of Science ®Google Scholar
• Beitel M, Oberleitner L, Muthulingam D, et al. Experiences of burnout among drug counselors in a large opioid treatment program: a qualitative investigation. Subst Abus. 2018;39(2):211–217.
   PubMed Web of Science ®Google Scholar
• Knudsen HK, Ducharme LJ, Roman PM. Clinical supervision, emotional exhaustion, and turnover intention: a study of substance abuse treatment counselors in NIDA’s Clinical Trials Network. J Subst Abuse Treat. 2008;35(4):387–395.
   PubMed Web of Science ®Google Scholar